Related content

Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury

By Cella Laura   Liuzzi Raffaele   D’Avino Vittoria   Conson Manuel   Di Biase Angela   Picardi Marco   Pugliese Novella   Solla Raffaele   Salvatore Marco   Pacelli Roberto  

Acta Oncologica, Vol. 53, Iss. 5, 2014-05 ,pp. : 613-619

Informa Healthcare

Access to resources Recommend Favorite

Risk of second malignancies in patients with early‐stage classical Hodgkin's lymphoma treated in a modern era

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 513-518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hodgkin's Disease in Patients Older Than 70 Years of Age: a Registry-based Analysis

By Forsyth P.D.   Bessell E.M.   Moloney A.J.   Leach I.H.   Davies J.M.   Fletcher J.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1638-1642

Elsevier

Access to resources Recommend Favorite